Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome (RAPIDA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2016 by Maastricht University Medical Center
Sponsor:
Collaborator:
FABPulous B.V.
Information provided by (Responsible Party):
Maastricht University Medical Center
ClinicalTrials.gov Identifier:
NCT01826994
First received: April 4, 2013
Last updated: March 17, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):